Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries
NCT ID: NCT03580980
Last Updated: 2018-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2015-04-01
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Intrathecal Morphine in Children
NCT03120403
intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain
NCT02726828
Comparison Between Low-dose Ketamine Infusion and Intravenous Morphine
NCT04281628
Ketamine Versus Morphine Change Pain Profile
NCT03664622
Efficacy of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain
NCT02620371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preemptive analgesia is defined as analgesic treatment that starts before surgical incision to prevent central sensitization caused by incisional and inflammatory injuries.However, studies in animal models of incisional pain demonstrated that single analgesic treatment before the incision does not reduce postoperative pain. Once nociceptive afferent block subsides, the wound reinitiates central sensitization. Also, clinical trials reported similar results.Multimodal analgesia uses a combination of delivery routes administered at variable time points to optimize outcomes in the treatment of acute pain.
Therefore, in this pilot study, the investigators are trying to evaluate safety and efficacy of preemptive multimodal analgesia compared with preemptive caudal analgesia and PCA morphine in pediatric cancer patient undergoing major abdominal surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drug: Morphine
Morphine Group C (n=30) was the control group who received IV morphine in a dose of 0.1 mg/kg after induction of anesthesia
Morphine
patient controlled analgesia by morphine
Procedure/surgery:Caudal levobupivacaine
In Caudal Group (n=30), patients were placed in the lateral position and received caudal epidural block after induction of anesthesia with levobupivacaine 0.125% , 1.1 ml/kg and morphine 0.02 mg/kg with maximum 20ml.
Caudal levobupivacaine
an epidural injection of morphine and levobupivacaine through the caudal space
Drug: Paracetamol and ketamine
The patients of Multimodal Group (n=30) received paracetamol infusion 10 mg/kg over 10 minutes and ketamine 0.5 mg/kg IV bolus followed by ketorolac 1 mg/kg infusion over 10 minutes.
Paracetamol and ketamine
intravenous paracetamol and ketamine followed by ketorolac
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paracetamol and ketamine
intravenous paracetamol and ketamine followed by ketorolac
Caudal levobupivacaine
an epidural injection of morphine and levobupivacaine through the caudal space
Morphine
patient controlled analgesia by morphine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 5 and 12 years.
* Both sexes.
* Scheduled for major abdominal surgery with a midline incision.
Exclusion Criteria
* Known or suspected allergy to any administered drugs.
* Active renal (creatinine clearance \<50).
* Hepatic (liver enzymes more than 10 folds).
* Respiratory (SPO2 \<92% on room air).
* Cardiac disease (ejection fraction \< 50%).
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ehab Hanafy Shaker
Clinical professor of Anesthesia ,Critical care and Pain medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ehab H Shaker, MD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute- Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesia and Pain medicine.National Cancer Institute
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Preventing chronic pain following acute pain: Risk factors, preventive strategies, and their efficacy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ehab-Hossam.multi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.